The Relationship Between Smoking Status and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus

Background/Objectives: This study aimed to investigate the relationship between smoking status and C-Peptide levels in patients with Type 2 Diabetes Mellitus (T2DM). Methods: The study included patients over the age of 18 with type 2 diabetes mellitus, without any malignancy, who presented to our hospital’s Internal Medicine Outpatient Clinic between January 2022 and April 2023. A total of 204 patients were recruited and examined in three groups: nonsmokers (n = 142), current smokers (n = 37), and former smokers (n = 25). Results: In the nonsmoker group, fasting c-peptide was significantly correlated with neck circumference (r = 0.202), waist circumference (r = 0.311), hip circumference (r = 0.270), insulin (r = −0.358), HbA1c (r = −0.235) and High Dense lipoprotein (r = −0.192). In the smoker group, fasting c-peptide was significantly correlated with diabetes age (r = −0.466), and sodium glucose cotransporter drugs (SGLT-2 inhibitor) usage (r = −0.335). In former smokers, fasting c-peptide was significantly correlated with SBP (r = −0.441), insulin (r = −0.578) and fasting blood sugar (r = 0.520; p < 0.01). In former smokers, fasting c-peptide (r = 0.522) and postprandial c-peptide (r = 0.505; p < 0.01) were significantly and positively correlated with smoking years. In former smokers, fasting c-peptide (r = −0.411) and postprandial c-peptide (r = −0.552) were significantly and negatively correlated with years since quitting. Multivariate analysis results showed that associations of fasting C-peptide levels with tease dummy (B = −1.176; p < 0.05) and insulin dummy (B = 0.052; p < 0.05) were statistically significant. Postprandial C-peptide was significantly associated with age (B = 0.077; p < 0.01), DM age (B = −0.074; p < 0.05), BMI (B = 0.177; p < 0.01) and insulin dummy (B = −2.910; p < 0.01). Conclusions: In former smokers, smoking years were positively correlated with both fasting and postprandial C-peptide levels in univariate analysis; however, this relationship was attenuated and became non-significant when evaluated within the multivariable regression model.

Authors

Institutions

Publication Details

Journal
Metabolites
Published
2026-11-09
DOI
https://doi.org/10.3390/metabo16110865
Primary Topic
Diabetes Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

The Relationship Between Smoking Status and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus

Müzeyyen Eryılmaz, İlkay Keskinel, Kadir Yılmaz, Arman Özer
Metabolites
Diabetes Treatment and Management
article

The Relationship Between Smoking Status and C-Peptide Levels in Patients with Type 2 Diabetes Mellitus

Müzeyyen Eryılmaz, İlkay Keskinel, Kadir Yılmaz, Arman Özer
article en

Abstract

Background/Objectives: This study aimed to investigate the relationship between smoking status and C-Peptide levels in patients with Type 2 Diabetes Mellitus (T2DM). Methods: The study included patients over the age of 18 with type 2 diabetes mellitus, without any malignancy, who presented to our hospital’s Internal Medicine Outpatient Clinic between January 2022 and April 2023. A total of 204 patients were recruited and examined in three groups: nonsmokers (n = 142), current smokers (n = 37), and former smokers (n = 25). Results: In the nonsmoker group, fasting c-peptide was significantly correlated with neck circumference (r = 0.202), waist circumference (r = 0.311), hip circumference (r = 0.270), insulin (r = −0.358), HbA1c (r = −0.235) and High Dense lipoprotein (r = −0.192). In the smoker group, fasting c-peptide was significantly correlated with diabetes age (r = −0.466), and sodium glucose cotransporter drugs (SGLT-2 inhibitor) usage (r = −0.335). In former smokers, fasting c-peptide was significantly correlated with SBP (r = −0.441), insulin (r = −0.578) and fasting blood sugar (r = 0.520; p < 0.01). In former smokers, fasting c-peptide (r = 0.522) and postprandial c-peptide (r = 0.505; p < 0.01) were significantly and positively correlated with smoking years. In former smokers, fasting c-peptide (r = −0.411) and postprandial c-peptide (r = −0.552) were significantly and negatively correlated with years since quitting. Multivariate analysis results showed that associations of fasting C-peptide levels with tease dummy (B = −1.176; p < 0.05) and insulin dummy (B = 0.052; p < 0.05) were statistically significant. Postprandial C-peptide was significantly associated with age (B = 0.077; p < 0.01), DM age (B = −0.074; p < 0.05), BMI (B = 0.177; p < 0.01) and insulin dummy (B = −2.910; p < 0.01). Conclusions: In former smokers, smoking years were positively correlated with both fasting and postprandial C-peptide levels in univariate analysis; however, this relationship was attenuated and became non-significant when evaluated within the multivariable regression model.

MetabolitesVol. 16(11)
Sağlık Bilimleri Üniversitesi (TR), Fatih Sultan Mehmet Eğitim Ve Araştırma Hastanesi (TR), Istanbul Commerce University (TR), Okan University (TR)
Diabetes Treatment and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon